Research Report on Drug Discovery Technologies Market 2024

Drug Discovery Technologies Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of Drug Discovery Technologies Market by technology type (biochips, high throughput screening, pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology), end users (biopharmaceutical, pharmaceutical, research institutes and biotech companies) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the Drug Discovery Technologies Market it includes the five years Industry analysis and the 6 years annual forecast from 2018 to 2024. Some of the prominent participants in the Global Drug Discovery Technologies Market are Agilent Technologies, Inc, Abbott Laboratories, Inc., GE Healthcare Ltd., Albany Molecular Research Inc., Affymetrix Inc., Arqule Inc., Luminex Corporation, Bayer Healthcare AG, Novartis AG, and Astrazeneca plc. According to report the global drug discovery technologies market is expected to grow at a CAGR of 18.4% over the forecast period of 2018 – 2024.

The Increasing Investment in the Field of Nanotechnology, Biotechnology, Genomics, and, Molecular Biology are some other Factor that has Driven this Market

The growing incidences of diseases, pathogen resistance to old drugs, patent expiries, and competition among drug manufacturers are the key factors that drive the growth of this market. Moreover, increasing investment in the field of nanotechnology, biotechnology, genomics, and, molecular biology are some other factor that has driven this market. Furthermore, long duration of drug discovery process, high initial setup cost and presence of strict regulatory surroundings.

Segments Covered

The report on global drug discovery technologies market covers segments such as technology type, and end users. The technology type segments include biochips, high throughput screening, pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology and others (RNAI, combinatorial chemistry). On the basis of end users the global drug discovery technologies market is categorized into biopharmaceutical companies, pharmaceutical companies, research institutes and biotech companies.

U.S. Drives the Growth in the North America Region As it is the Largest Market in the Region

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2016 – 2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea and Malaysia among others. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2018 – 2024.

Major Key Players Mentioned in this Premium Report

The report provides profiles of the companies in the global drug discovery technologies market such as, Agilent Technologies, Inc, Abbott Laboratories, Inc., GE Healthcare Ltd., Albany Molecular Research Inc., Affymetrix Inc., Arqule Inc., Luminex Corporation, Bayer Healthcare AG, Novartis AG, and Astrazeneca plc.

Table Of Contends

1. Preface

1.1 Report Description

1.2 Research Methods

1.3 Research Approaches

2.Executive Summary

3.Global Drug Discovery Technologies Market Overview

3.1 Introduction 

3.2 Market Dynamics  

3.2.1Drivers

3.2.2 Restraints

3.2.3 Opportunities

3.3 Porter’s Five Forces Analysis 

3.4 IGR – Growth Matrix Analysis

3.5 Competitive Landscape in the Global Drug Discovery Technologies Market 

4. Global Drug Discovery Technologies Market by Technology Type 2018 – 2024

4.1 Biochips

4.2 High throughput screening   

4.3 Pharmacogenomics  

4.4 Genomics

4.5 Bioanalytical instruments

4.6 Bioinformatics 

4.7 Nanotechnology

4.8 Others (RNAi, combinatorial chemistry) 

5. Global Drug Discovery Technologies Market by End Users 2018 – 2024

5.1 Biopharmaceutical companies 

5.2 Pharmaceutical companies   

5.3 Research institutes   

5.4 Biotech companies  

6. Global Drug Discovery Technologies Market by Regions 2018 – 2024

6.1 North America 

6.1.1 North America Drug Discovery Technologies Market by Technology Type

6.1.2 North America Drug Discovery Technologies Market by End Users

6.1.3 North America Drug Discovery Technologies Market by Country

6.2 Europe 

6.2.1 Europe Drug Discovery Technologies Market by Technology Type

6.2.2 Europe Drug Discovery Technologies Market by End Users

6.2.3 Europe Drug Discovery Technologies Market by Country

6.3 Asia-Pacific   

6.3.1 Asia-Pacific Drug Discovery Technologies Market by Technology Type

6.3.2 Asia-Pacific Drug Discovery Technologies Market by End Users

6.3.3 Asia-Pacific Drug Discovery Technologies Market by Country

6.4  RoW

6.4.1 RoW Drug Discovery Technologies Market by Technology Type

6.4.2 RoW Drug Discovery Technologies Market by End Users

6.4.3 RoW Drug Discovery Technologies Market by Region

7. Companies Covered

7.1 Agilent Technologies, Inc

7.2 Abbott Laboratories, Inc.

7.3  GE Healthcare Ltd.   

7.4  Albany Molecular Research Inc. 

7.5  Affymetrix Inc. 

7.6  Arqule Inc.   

7.7  Luminex Corporation  

7.8  Bayer Healthcare AG  

7.9  Novartis AG  

7.10 Astrazeneca plc

Click the Below Full Report Link

https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_drug_discovery_technologies_market



Reset Password